Drug Trial Radar · NCT03957720
The Individual Therapy for Patients With Wilson's Disease
Last checked: Nov 20, 2026Latest source record: May 21, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
400
Planned (sponsor's estimate)
Start
Mar 15, 2019
Primary completion
Dec 31, 2024
Study completion Dec 31, 2024
Sponsor
- Lead sponsor
- Second Affiliated Hospital, Zhejiang University, School of MedicineAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- May 21, 2019
Design
- Study type
- Interventional
- Phase
- Early phase 1
- Allocation
- Non randomized
- Model
- Sequential
- Masking
- Single (participant)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Based on the genotype characteristics and genotype-phenotype-treatment prognosis data of Chinese WD patients, this study intends to further optimize the treatment regimen of Chinese WD patients and formulate individualized treatment regimens for each genotype, so as to further improve the prognosis of patients.
Conditions
- Wilson's Disease
Interventions
DMPSDrug
Dosage Form: DMPS: 500-1000mg per day,DMPS Frequency:BID,DMPS Duration: 6 days;
PenicillamineDrug
Dosage Form: Penicillamine: 250-1500mg per day, Frequency:TID,Duration: 5 years;
DMSADrug
Dosage Form: DMSA: 750-1000mg per day,DMSA Frequency:BID,DMSA Duration: 5 years; Dosage Form: DMSA: 35mg/kg per day,DMSA Frequency:BID,DMSA Duration: 5 years;
Zinc gluconateDrug
Dosage Form: Zinc gluconate: 140mg per time,Zinc Frequency:BID,Zinc Duration: 5 years; Dosage Form: Zinc gluconate: 140mg per time,Zinc Frequency:TID,Zinc Duration: 5 years; Dosage Form: Zinc gluconate: 210mg per time,Zinc Frequency:TID,Zinc Duration: 5 years;
Primary outcomes
What the sponsor says the trial is designed to measure.
- Serum ceruloplasminTime frame: Five years
- 24-hour urine copperTime frame: Five years
- serum copperTime frame: Five years
- White blood cellTime frame: Five years
- Platelet countTime frame: Five years
- urine protein levelTime frame: Five years
- Alanine transaminaseTime frame: Five years
- blood creatinineTime frame: Five years
- international normalized ratioTime frame: Five years
- hepatic fibrosis markers testTime frame: Five years
- bone mineral density testTime frame: Five years
- Abdominal ultrasoundTime frame: Five years
- Urinary ultrasoundTime frame: Five years
- Cranial MRI scanTime frame: Five years
- Unified Wilson's disease rating scaleTime frame: Five years
Locations
1 site in 1 country. Site status is shown where the registry gives one.
econd Affiliated Hospital,Zhejiang University School of Medicine
Hangzhou, Zhejiang, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.